Spindletop Health Acquisition, a blank check company targeting the US healthcare industry, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50.
The company is led by CEO, CFO, and Director Evan Melrose, the founder and Managing Director of Spindletop Capital, and Chairman James Henry, who spent nearly four decades at PricewaterhouseCoopers, most recently serving as Global Healthcare Leader. Spindletop Health Acquisition intends to focus its investment efforts broadly across the entire healthcare and healthcare-related industries in the United States, with an emphasis on healthcare services, healthcare information technology, insurance and related products, biotechnology, pharmaceuticals, medical devices, and diagnostics.
Spindletop Health Acquisition plans to list on the Nasdaq under the symbol SHCAU. Barclays and Stifel acted as joint bookrunners on the deal.
